J R Sherwood
Overview
Explore the profile of J R Sherwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schiff G, Sherwood J
J Infect Dis
. 1999 Dec;
181(1):20-6.
PMID: 10608746
A randomized, double-blind study assessed the efficacy and safety of pleconaril, a novel antiviral drug with broad-spectrum activity against picornaviruses, in the treatment of 33 adults with an experimentally induced...
2.
Bernstein D, Smith V, Sherwood J, Schiff G, Sander D, DeFeudis D, et al.
Vaccine
. 1998 Jun;
16(4):381-7.
PMID: 9607059
The safety and immunogenicity of an orally administered live human rotavirus vaccine candidate (89-12), attenuated by 33 passages in monkey kidney cells, were evaluated in placebo-controlled trials in adults, children...
3.
Schiff G, Sherwood J, Zeldis J, Krause D
J Adolesc Health
. 1995 Jan;
16(1):12-7.
PMID: 7742331
Purpose: A prospective, two-armed, open-label, randomized trial was performed to compare the geometric mean titers (GMT), seroprotection (SP) and seroconversion (SC) rates found after administration of two doses of recombinant...
4.
Ward R, Pax K, Sherwood J, Young E, Schiff G, Bernstein D
J Med Virol
. 1992 Mar;
36(3):222-5.
PMID: 1314287
To determine whether salivary antibody is a reliable indicator of rotavirus infection and mucosal rotavirus antibody concentrations, salivary rotavirus antibody titers were determined as a function of time following inoculation...
5.
Ward R, Bernstein D, Knowlton D, Sherwood J, Young E, Cusack T, et al.
J Clin Microbiol
. 1991 Sep;
29(9):1991-6.
PMID: 1663519
A model was developed to examine the effects of disinfectants on the transmission of infectious rotavirus from a dried surface to humans. The initial experiments were designed to find a...
6.
Reuman P, Bernstein D, Keely S, Sherwood J, Young E, Schiff G
Antiviral Res
. 1990 Mar;
13(3):103-10.
PMID: 2353803
Four influenza A challenge studies were performed over a period of three years using the same dose of one virus pool. The first three studies were conducted two influenza seasons...
7.
Ward R, Bernstein D, Shukla R, McNeal M, Sherwood J, Young E, et al.
J Infect Dis
. 1990 Mar;
161(3):440-5.
PMID: 2155972
Previous studies of adults challenged with human rotavirus (CJN strain) showed that 74% became infected and 55% of those infected experienced illness. Protection against infection correlated with rotavirus antibody, most...
8.
Reuman P, Bernstein D, Keely S, Young E, Sherwood J, Schiff G
J Med Virol
. 1989 Feb;
27(2):137-41.
PMID: 2921600
Anti-influenza serum and nasal antibody titers were followed during a double-blind, placebo-controlled, randomized study assessing the prophylactic efficacy of 50, 100, and 200 mg/day of amantadine hydrochloride against experimental challenge...
9.
Reuman P, Bernstein D, Keefer M, Young E, Sherwood J, Schiff G
Antiviral Res
. 1989 Feb;
11(1):27-40.
PMID: 2712549
The efficacy and safety of prophylactic low dose amantadine hydrochloride was assessed in two double-blind, placebo-controlled, randomized studies. In a study of 476 subjects aged 18 to 55 years, adverse...
10.
Ward R, Bernstein D, Shukla R, Young E, Sherwood J, McNeal M, et al.
J Infect Dis
. 1989 Jan;
159(1):79-88.
PMID: 2535868
Effects of preinoculation rotavirus antibody titers on the probability of infection and illness were evaluated in adults challenged orally with different doses of a virulent human rotavirus (CJN strain). Preinoculation...